Abstract:The combination of several drugs is often necessary, especially during long-term therapy. Drug-protein interaction has attracted a great deal of research interest because only the free drug fraction exerts pharmacological and/or toxicological effects. Herein, the binding interactions of serum transport protein, human serum albumin (HSA), with individual or combined anticancer drugs, (−)-epigallocatechin-3-gallate (EGCG) and 5-fluorouracil (FU), were investigated using isothermal titration calorimetry (ITC), circular dichroism (CD), and dynamic light scattering (DLS). DLS measurements showed that EGCG has a larger effect on the hydrodynamic diameter of HSA than FU. The adding order of EGCG and FU has an important influence on the size of the EGCG+FU+HSA complex. Fitting of the ITC data suggested that there are two sets of sites for the individual and combined binding of EGCG and FU to HSA. The obtained thermodynamic parameters revealed that electrostatic, hydrogen bonding, and van der Waals interactions may contribute to the stronger affinity of EGCG while hydrophobic interactions, van der Waals forces, and hydrogen bonding are the major forces in stabilizing the FU+HSA complex. The largest free concentrations of EGCG and FU are attained at pH7.4 and 8.4 respectively, due to the pH dependence on the number of binding sites and binding constants. The discrepancy in the free concentration between the binary and ternary systems implies the competitive binding of EGCG and FU to HSA. Changes in the secondary structure of HSA due to the addition of EGCG and FU at different pHs were discussed based on CD measurements. The calorimetric and spectroscopic results can provide quantitative information on the binding characteristics and suggest that the competitive binding of EGCG and FU to HSA may enhance anticancer effects. These results can provide a deeper understanding of combination therapy.

Analysis on the interaction and binding properties of daphnoretin and human serum albumin in the presence of cisplatin: multi-spectroscopic methods and docking simulation

Noncovalent Interactions Between a Trinuclear Monofunctional Platinum Complex and Human Serum Albumin.

Spectroscopic and cytotoxicity studies on the combined interaction of (−)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin

Drug-protein Binding of Danhong Injection and the Potential Influence of Drug Combination with Aspirin: Insight by Ultrafiltration LC–MS and Molecular Modeling

Study on the Interactions Between Cisplatin and Cadherin by Fluorescence Spectrometry and Atomic Force Microscopy.

Competitive binding of (−)-epigallocatechin-3-gallate and 5-fluorouracil to human serum albumin: A fluorescence and circular dichroism study

Study on the interactions between cisplatin and cadherin

Unveiling the molecular mechanism of pH-dependent interactions of human serum albumin with chemotherapeutic agent doxorubicin: A combined spectroscopic and constant-pH molecular dynamics study

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer

Molecular Interaction Study of Flavonoid Derivative 3d with Human Serum Albumin Using Multispectroscopic and Molecular Modeling Approach

A comprehensive investigation of the nano-[Cu2-(DIP)2-EA] effects on HSA through spectroscopic procedures and computer simulations

Comparative investigation on interaction mechanism and native conformation of human serum albumin with organometallic iridium(III) complexes via spectroscopic and electrochemical approaches

Calorimetric and spectroscopic studies on the competitive behavior between (−)-epigallocatechin-3-gallate and 5-fluorouracil with human serum albumin

A Near Infrared Light-Triggered Human Serum Albumin Drug Delivery System with Coordination Bonding of Indocyanine Green and Cisplatin for Targeting Photochemistry Therapy Against Oral Squamous Cell Cancer

Exploring the molecular basis of tucatinib interaction with human serum albumin: A spectroscopic and computational analysis

DNA interactive and selective anticancer activity studies of copper(II) complexes decorated water‐soluble porphyrin

Theoretical investigation on hydrolysis mechanism of cis-platin analogous Pt(II)/Pd(II) complex by DFT calculation and molecular docking approach for their interaction with DNA & HSA

Multispectroscopic, electrochemical and molecular docking approaches on binding comparison of camptothecin, 10-hydroxycamptothecin to bovine serum albumin

Multiple Spectroscopic, Docking and Cytotoxic Study of a Synthesized 2,2′ Bipyridin Phenyl Isopentylglycin Pt(II) Nitrate Complex: Human Serum Albumin and Breast Cancer Cell Line of MDA-MB231 as Targets

The effect of simultaneous binding of doxorubicin and cyclophosphamide on the human serum albumin structure

The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt–DNA adducts